#1 Womens Brian O'Neill Jersey von gsnoopy520 22.12.2018 06:38

Migraine Drugs Market to Attain a Value of US$ 3.72 Bn by the End of 2025
by Metcarl · November 21 Chidobe Awuzie Limited Jersey , 2018

The global migraine drugs market has considerable room for growth in the absence of a permanent cure for the condition and growing genericization of drugs. Hence, established companies in the market are seen upping allocations on research and development to come up with better drugs to satisfy the unmet demands, and thereby grow their sales and revenues. In the upcoming years, the market is expected to see entry of aspiring players too. All these will help to increase competition.

Read Report Overview @

Migraine is a common occurrence worldwide. Hence, with the increasing global population, particularly female population 鈥?who are more prone to have migraine, the market for the drugs will likely rise at a steady pace. Posing a challenge to the market Taco Charlton Limited Jersey , on the downside, is the easy availability of generics and over reliance on over the counter (OTC) pain killers and other drugs in emerging and under developed markets.

As per a report by Transparency Market Research, the global migraine drugs market will likely expand at a lackluster CAGR of 3.5% during the period between 2017 and 2025 to become worth US$3.72 bn by 2025 from US$2.72 bn in 2016.

Depending upon the available treatments, the global market for migraine drugs can be divided into abortive treatment and prophylactic treatment. The abortive treatment can be further segmented into triptans, ergot alkoids, etc. The prophylactic treatment segment can be further divided into botulinum toxin, topiramate Connor Williams Limited Jersey , etc. At present, the segment of abortive treatment leads the market with a higher share. The triptans are primarily powering the growth of the segment. The segment of prophylactic treatment is also expected to see steady growth in the next couple of years on the back of topiramate, which will likely rise at 3.4% CAGR in the forecast period. Increasing incidences of chronic migraine and rise in inclination towards prophylactic treatment of migraine is projected to fuel this growth.

Request for the Sample Report @ ;rep_id=31136

Depending upon the route of administration, global migraine drugs market can again be classified into injectable, oral, and others including nasal sprays, transdermal patches Leighton Vander Esch Limited Jersey , etc. Of them, oral route of administration accounts for a dominant share in the market because of their relatively cheaper price and easy availability of orally administrable drugs, namely triptans and topiramate.

Geographically, North America currently runs the show in the global migraine drugs market. In future

Xobor Forum Software von Xobor.de
Einfach ein Forum erstellen